Shares of Rocket Lab surged +10.5% to $58.65 on November 9, as a manufacturing milestone on the company's next-generation Neutron rocket collided with investor positioning ahead of Q3 earnings, due after today's close. The move caps a volatile week that saw the stock swing from $45.99 to nearly $59, raising a pointed question: how much future success is already baked into the price? Rocket Lab Fixes Neutron's Dome Flaw and Investors Pile In Before Earnings — But Is a $34 Billion Bet on an Unflown Rocket Getting Ahead of Itself?
Shares of Rocket Lab vaulted 10.5% to $58.65 as two catalysts converged: confirmation that the replacement forward dome for the company's next-generation Neutron rocket has been built and cured, and positioning ahead of Q3 earnings due after today's close. The question for shareholders is whether a stock trading at roughly 56 times forward revenue can keep climbing on incremental hardware progress while the rocket itself has never left the ground.
A Carbon-Fiber Fix Restores Some Confidence, but Testing Isn't Over. In October, CEO Peter Beck disclosed that inspectors found tiny air pockets — voids — inside the carbon-composite layers of Neutron's forward propellant dome, pushing the debut flight to 2027.
Rocket Lab reproduced the defect, introduced process fixes, and successfully produced the rear dome — which Beck called the highest-quality composite dome the company has made. The replacement forward dome is now built and cured, but it must still pass ultrasonic analysis and material testing before tank assembly can proceed.
Beck expects testing of the problematic components to wrap up by the end of Q1 2027, at which point a new launch date will be set. Each additional quarter of delay extends the period Rocket Lab burns cash on a program that has generated zero revenue.
Q3 Numbers Will Test Whether the Core Business Justifies the Valuation. Analysts expect Rocket Lab to post a loss of $0.07 per share on revenue of $257 million, up roughly 66% year-over-year.
Space systems — satellite hardware and components — contributed about 81% of Q2 revenue and operates independently of Neutron.
Total backlog reached a record $2.36 billion as of June 30. Those are real numbers, but the company still posts operating losses; Q2's GAAP operating loss was $57.5 million as Neutron spending continues.
The Stock's Wild Week Signals Fragile Sentiment. Shares dropped to $45.99 on November 5 before snapping back +15% the next day and another +10.5% today — a 27% swing in three sessions. The price-to-sales ratio sits around 67x , and the market cap is approximately $34 billion on roughly $600 million in trailing annual revenue. That premium prices in not just Neutron's success but its timely success — something the program's fourth schedule slip makes harder to guarantee.
The Bottom Line. Rocket Lab's space-systems business is growing fast and the dome fix is genuinely encouraging. But investors paying a historically steep valuation are betting that an unflown rocket will rewrite the company's economics. Tonight's earnings call — and any updated Neutron timeline — will determine whether the rally has legs or is running on fumes.